Physician profile
Cameron Ramsay
NPI 1255455929
$2,211.16
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $81.89 · 2021: $91.57 · 2022: $110 · 2023: $1,336 · 2024: $220 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130 · Travel and Lodging: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.30 |
| Travel and Lodging | $568.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,339.44 | 2019-2024 | Optis, Perclose Prostyle |
| Boston Scientific Corporation | $280.29 | 2022-2025 | Avvigo Guidance System, Synergy, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $95.20 | 2022-2025 | |
| Amgen INC. | $84.27 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $82.57 | 2019-2020 | |
| Philips North America LLC | $59.42 | 2021-2022 | |
| Shockwave Medical, INC | $44.79 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.71 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $37.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $31.72 | 2019-2022 | |
| Abiomed | $23.83 | 2023 | Impella |
| Heartflow, INC. | $23.33 | 2025 | |
| Pfizer INC. | $20.59 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.44 | 2019 | |
| Medtronic Vascular, INC. | $13.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Ramsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.